Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: June 28, 2022

Eywa Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for EYWA, and what generic and branded alternatives to EYWA drugs are available?

EYWA has sixteen approved drugs.

Summary for Eywa

US Patents:	0
Tradenames:	15
Ingredients:	15
NDAs:	16

Drugs and US Patents for Eywa

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Eywa Pharma	ACETAZOLAMIDE	acetazolamide	TABLET;ORAL	211556-001	Oct 18, 2019	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Eywa Pharma	ALOSETRON HYDROCHLORIDE	alosetron hydrochloride	TABLET;ORAL	211621-001	Sep 16, 2019		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Eywa	OXYBUTYNIN CHLORIDE	oxybutynin chloride	TABLET;ORAL	211062-001	Feb 6, 2019	BX	RX	No	No		See Plans and Pricing				See Plans and Pricing
Eywa	POTASSIUM CITRATE	potassium citrate	TABLET, EXTENDED RELEASE;ORAL	214426-002	Feb 19, 2021	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Eywa	LABETALOL HYDROCHLORIDE	labetalol hydrochloride	TABLET;ORAL	207863-002	Feb 4, 2019	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Eywa	METHYLPHENIDATE HYDROCHLORIDE	methylphenidate hydrochloride	SOLUTION;ORAL	210139-002	Oct 3, 2018	AA	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

Harvard Business School

Colorcon

Johnson and Johnson

Dow

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.